Medical Imaging Markets Market Research Bundle (X-Ray, Digital X-Ray, CT, SPECT, MRI, Ultrasound, Contrast Agents, Molecular Imaging)

 
   Single User - $4,995
   Site License (one location, 10 users) - $7,500
   Corporate License - $9,990


Loading...
Published Feb 5, 2013 | 680 Pages | Pub ID: KLI4960453

This report, The Kalorama Medical Imaging Market Research Bundle, features 4 complete Kalorama Information studies in one cost-saving bundle.   With a total of 670 pages of coverage, 180 charts and figures and over 150 company profiles, this bundle provides market size estimates and forecasts, market share determinations, company profiles and trend analysis for every important modality of in-vivo imaging.  The four reports included in the bundle were published between 2011 and 2012.   The bundle contains the four reports in one PDF with separate tables of contents.  The following reports are included:


Medical Imaging Markets: X-Ray, Digital X-Ray, CT and Other Radiography Systems (pub. 11/2011)

 Medical Imaging Markets: X-Ray, Digital X-Ray, CT and Other Radiography Systems from Kalorama Information, details these factors and provides 2011 market size and forecast to 2015 for the following markets:

  • Digital X-Ray
  • Traditional X-Ray
  • Dental X-Ray
  • Film
  • CT
  • Mammography
  • Fluoroscopy
  • Regional Markets (US, Europe, Asia, ROW) for these segments
Digital systems replace the conventional film cassette with an electronic receptor that directly converts the x-rays to digital images. Over the years, Kalorama Information analyst Joe Constance has tracked this trend of digital radiography. Digital technology enables x-ray modalities to detect problem sites more rapidly and with greater accuracy. These capabilities are helping fuel hospitals’ transition from film-based systems to filmless environments. At the same time there are practical limiters to digital and areas where film-based systems will still be useful, and the report details these.

Medical Imaging Markets: MRI and Ultrasound (published 3/2012)

This report analyzes the current and potential world market for medical MRI and ultrasound systems. This report generally reviews the nature and direction of research, as well as future markets for two key areas of imaging technology: Ultrasound and MRI.
the report includes the following as part of its market coverage:

  • Current Market Size and Forecast for MRI Systems
  • Installed Base of MRI Systems (Open, Closed, Low to Mid Field, High Field)
  • Estimated Cost of MRI Systems
  • Current Market Size and Forecast for Ultrasound Systems
  • Installed Base of Ultrasound Systems
  • Estimated Cost of Ultrasound Systems
  • Regional Breakdown - World, US, Europe, Asia, and Country-Level Statistics
  • Major Trends Driving Growth
  • Review of Products on the Market
  • Profiles of Key Companies.
The information presented in Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound is the result of data gathered from company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press. In addition, interviews were conducted with company executives, clinicians and researchers.

Medical Imaging Markets: Contrast Agents (published 7/2012)

This comprehensive study of the world market for contrast agents builds on the previous modality-focused reports of Kalorama's medical imaging market reports. Coverage includes:

  • World and regional revenue forecasts for contrast agents and radiopharmaceuticals by modality through 2016. (X-Ray, CT, Ultrasound, MRI, PET, SPECT)
  • Market share of the major contrast agent supplers
  • Procedure volumes by modality and region
  • Estimates of the portion of procedures in each modality using contrast enhancement
  • Contrast-enhancement products in development

The report also discusses technical developments and emerging application trends such as therapeutic monitoring, whole body screening, and guided therapeutic interventions, and how contrast agents are helping to expand imaging’s role in basic research and drug discovery/development. Specific advances in contrast agent-enabled diagnostics for mammography, Alzheimer’s, and other indications are also reviewed.

Generally, the market for contrast agents and radiopharmaceuticals is expected to sustain decent growth in the next few years, with much of that growth coming from the MRI, ultrasound and nuclear medicine modalities. While equipment manufacturers may have experienced a slump in sales due to the recent recession, there is still a need for these agents,as well as for radiopharmaceuticals, to help image, track and diagnose disease, especially in the elderly. Even though hospitals and clinics may have slowed their equipment purchases because of the need to contain costs, procedures run on installed systems still require the use of contrast agents and radiopharmaceuticals.

This comprehensive study of the world market for contrast agents builds on the previous modality-focused reports of Kalorama's medical imaging market reports.


Medical Imaging Markets: Molecular Imaging (published 9/2012)

Medical Imaging Markets: Molecular Imaging offers complete market coverage of world markets for molecular imaging products for the following technologies:

  • PET
  • SPECT-Gamma Camera Systems
  • MRI
  • CT
  • Ultrasound
  • SPECT/CT
  • PET/CT
For each of these modalities, the report provides current market size based on revenues to manufacturers of imaging systems used for molecular procedures, as well as forecasts of future revenues.

Interest in and use of the technology has exploded in recent years, thanks to advances in cell biology, biochemical agents, and computer analysis, and serious market watchers in medical imaging industries, as well as those serving or investing in medical imaging companies, will want to keep abreast of this new market. As part of its comprehensive coverage, Medical Imaging Markets: Molecular Imaging includes:

  • Overview and Explanation of modalities and key applications
  • Over 34 Figures and Tables to make market data accessible to users
  • Review of Imaging Agents in Clinical Trials, or that are recently introduced
  • Market Size and Forecasts are developed through 2015
  • Profiles of Top Competitors in the industry
  • Breakout of Regional Markets for Molecular Imaging – including BRIC markets
  • Kalorama looks at the technologies currently used in molecular imaging but also examines novel research areas, such as:
  • Diagnosing Fever of Unknown Origin
  • Determine Malignancy in Potential Ovarian Cancer
  • PET/CT Impacts Brain Tumor Management
  • Improving Care for Neuroendocrine Cancer
  • PET Optimizes Virtual Colonoscopy
  • Staging Prostate Cancer
  • Cyclotron Expansion
  • Breast Cancer Screening
  • PET Indicates Therapy Effectiveness
  • Lower Dosage in Hybrid Imaging
  • Analyze Differences in Biochemical Status of Tissues
  • Myocardial Flow Reserve Analysis
Market forecasts are based on an examination of current market conditions and on investigations into the development of new products by key companies. The market data provide multiple year forecasts for different product segments covered in the report. The information presented in this report is the result of data gathered from company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press. In addition, interviews were conducted with company executives, clinicians and researchers.

The general aging of the population continues to build the need for diagnosticimaging services. While the aging population is one trend likely to affect imagingprocedure volumes, the behavioral and lifestyle trends of the world population are alsolikely to increase the need for imaging procedures. One example involves obesity, which is often linked to increased risks of cardiovascular disease, diabetes, hypertension, and other illnesses. Imaging is well suited to the diagnosis and management of many age-related diseases such as cardiovascular, cancer, inflammatory and neurological diseases. These diseases are becoming increasingly prevalent as the percentage of elderly people in the population rises. In the US, cancer and cardiovascular disease kill nearly 2 million people each year. According to the American Heart Association 

X-RAY, DIGITAL X-RAY, MAMMOGRAPHY AND OTHER RADIOGRAPHY MARKETS

CHAPTER ONE: EXECUTIVE SUMMARY
  • X-Ray Analysis
  • Digital X-Ray Evolution
    • Boosting Efficiency
  • Significant Uses
    • Chest X-Rays
    • Mammography
    • Economics
    • Cardiovascular Disease
  • Market Analysis
    • Traditional X-Ray
    • Digital X-Ray
    • Mammography
    • Fluoroscopy
    • Dental
  • Methodology
CHAPTER TWO: INTRODUCTION
  • Early Diagnostic Tool
  • History
  • The Onset of Digitization
    • 3D X-Ray
  • Transition to Digital
    • Focus and Risk Reduction
    • Changes in Behavior
    • The Private Practice and Its Needs
  • Computed Radiography
      Readers
  • Digital Economics
  • Improved Throughput
  • Machine Vision Opportunities
CHAPTER THREE: KEY APPLICATIONS
  • Chest Imaging
    • Multi-Drug Resistance
    • National Lung Cancer Screening Trial Update
    • Types of Cancers Found by Screening
  • Mammography
    • CR Mammography
    • Tomosynthesis
    • Approved FFDM Accreditation Bodies
    • Functional Imaging Alternatives
    • PEM Alternatives
    • CAD
    • Early Breast Cancers
    • Economic and Effectiveness Issues
    Cardio and Vascular Imaging Computed Tomography
    • Multislice CT
    • Evolution Continues
    • The Virtual Colon
    Fluoroscopy
    • Pediatric Fluoroscopy
    Orthopedics Laser Printers Dental Systems
    • Digital Implications
    Cone Beam Computed Tomography for Dentistry
    • Cone Beam Computed Tomography for Medical Surgery
    Challenges and Issues
    • Private Practices
    • Modifying Working Behavior
    • Design Considerations
    • Advances in Innovation
    • New Guidance Requirements
    • Economics
    • Return on Investment
CHAPTER FOUR: ONGOING RESEARCH
  • Chest X-Rays Yielding to New Technologies
  • Double CT Scans Unnecessary
  • CR and DR Over Conventional Modalities
  • CT Scans Optimize Accuracy in ER
  • ERs See Increase in CT Diagnostics
  • CT Angiography Identifies Heart Issues
  • CT Colonography for Screening
  • First Diagnostic Radiology Application for Mobile Devices
  • New Cardiac Imaging Device
  • CT Visualizes Nano-Structure of Bones
  • 3D Orthopedic Imaging
    • PET/CT May Offer Effective Breast Cancer Detection
  • Screening with Low-Dose Spiral CT Reduces Lung Cancer Deaths
  • CT Spots Seeds of Heart Disease in Healthy Patients
  • GE Moving Top X-Ray Executives to China
  • GE Launches Compact CT
  • Samsung Interested in Buying X-Ray Makers to Take on GE, Siemens
CHAPTER FIVE: MARKETS
  • General Radiography - Systems and Film
  • Mammography
    • Computer-Aided Detection
  • Computed Tomography
  • Fluoroscopy
  • Dental
CHAPTER SIX: CORPORATE PROFILES
  • Adimec
  • AFP Imaging Corp.
  • Agfa-Gevaert NV
  • Alara Inc.
  • Analogic Corp.
  • Applied Visual Sciences
  • Aribex Inc.
  • Biolase Technology
  • Biospace Med
  • Canon Inc.
  • Carestream Health Inc.
  • C.M.C. Biotech Co. Ltd.
  • CMT Medical Technologies Ltd.
  • Control-X Medical Inc.
  • dpiX LLC
  • Fischer Industries Inc.
  • Fujifilm Medical Systems USA Inc.
  • GE Healthcare
  • Hamamatsu Photonics KK
  • Hitachi Medical Systems America Inc.
  • Hologic Inc.
  • iCAD Inc.
  • Imaging Dynamics Co. Ltd.
  • ImaSight Inc.
  • Imix ADR
  • InfiMed Inc.
  • Internazionale Medico Scientifica
  • Italray
  • Lodox Systems
  • Medlink Imaging LLC
  • MedicaTech USA
  • M. E. X’Ray India Pvt. Ltd.
  • MinXray Inc.
  • MX Imaging Inc.
  • NeuroLogica Corp.
  • PerkinElmer
  • Philips Healthcare
  • Planmeca Oy
  • Plexus Corp.
  • R2 Technology Inc.
  • Radlink Inc.
  • Samsung Electronics America Inc.
  • Sectra Imtec AB
  • Shimadzu Corp.
  • Siemens Healthcare
  • Sirona Dental Systems, Inc.
  • Stephanix
  • Swissray International Inc.
  • Thales
  • Toshiba America Medical Systems
  • Tower Semiconductor Ltd.
  • Trixell
  • United Radiology Systems Inc.
  • Varian Medical Systems
LIST OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
  • Table 1-1 Methods of Digital X-Ray Generation
  • Table 1-2 World Market for Medical X-ray Equipment
  • Table 1-3 World Market for Digital Medical X-ray Equipment
  • Table 1-4 World Market for Mammography Systems
  • Table 1-5 World Market for Digital Mammography Systems
  • Table 1-6 World Market for Fluoroscopy Systems
  • Table 1-7 World Market for Dental X-ray Systems
CHAPTER TWO: KEY APPLICATIONS
  • Table 2-1 New US Cases of Invasive Breast Cancer -- Women
  • Table 2-2 New US Cases of Invasive Breast Cancer - Men
CHAPTER FIVE: MARKETS
  • Table 5-1 World Market for X-Ray Equipment
  • Table 5-2 North American Market for X-Ray Equipment
  • Table 5-3 European Market for X-Ray Equipment
  • Table 5-4 Asian Market for X-Ray Equipment
  • Table 5-5 Rest of World Market for X-Ray Equipment
  • Table 5-6 World Market for Digital X-Ray Equipment
  • Table 5-7 North American Market for Digital X-Ray Equipment
  • Table 5-8 European Market for Digital X-Ray Equipment
  • Table 5-9 Asian Market for Digital X-Ray Equipment
  • Table 5-10 Rest of World Market for Digital X-Ray Equipment
  • Table 5-11 World Medical Market for X-Ray Film
  • Table 5-12 US Medical Market for X-Ray Film
  • Table 5-13 Key Players’ Percentage Share - Worldwide Medical X-Ray Equipment Market
  • Table 5-14 World Market for Mammography Equipment
  • Table 5-15 North American Market for Mammography Equipment
  • Table 5-16 World Market for Digital Mammography Equipment
  • Table 5-17 North American Market for Digital Mammography Equipment
  • Table 5-18 Market Penetration of CAD Systems for Mammography
  • Table 5-19 World Market for CAD Systems
  • Table 5-20 North American Market for CAD Systems
  • Table 5-21 World Market for Computed Tomography Equipment
  • Table 5-22 North American Market for Computed Tomography Equipment
  • Table 5-23 European Market for Computed Tomography Equipment
  • Table 5-24 Asian Market for Computed Tomography Equipment
  • Table 5-25 Rest of World Market for Computed Tomography Equipment
  • Table 5-26 Key Players’ Percentage Share - Worldwide CT Market
  • Table 5-27 World Market for Fluoroscopy Equipment
  • Table 5-28 North American Market for Fluoroscopy Equipment
  • Table 5-29 European Market for Fluoroscopy Equipment
  • Table 5-30 Asian Market for Fluoroscopy Equipment
  • Table 5-31 Rest of World Market for Fluoroscopy Equipment
  • Table 5-32 World Market for Dental X-ray Equipment
  • Table 5-33 North American Market for Dental X-Ray Equipment
  • Table 5-34 European Market for Dental x-Ray Equipment
  • Table 5-35 Asian Market for Dental X-Ray Equipment
  • Table 5-36 Rest of World Market for Dental X-Ray Equipment
  • Table 5-37 Installed Base of Wall-Mounted Dental X-Ray Units 2010
  • Table 5-38 Potential for Dental Conversion to Digital X-Ray 2010
  • Table 5-39 World Dental Market for X-Ray Film
  • Table 5-40 US Dental Market for X-Ray Film

MRI AND ULTRASOUND MARKETS

1.0 EXECUTIVE SUMMARY

  • 1.1 MRI
    • 1.1.1 Opportunities from 3T
  • 1.2 Ultrasound
    • 1.2.1 Evolving Markets
  • 1.3 Key Challenges and Opportunities
    • 1.3.1 MRI
    • 1.3.2 Ultrasound
  • 1.4 World Market Growth
    • 1.4.1 MRI
    • 1.4.2 Ultrasound
  • 1.5 Methodology
2.0 APPLICATIONS
  • 2.1 Key Applications
    • 2.1.1 MRI
    • 2.1.2 Ultrasound
3.0 OVERVIEW
  • 3.1 MRI
    • 3.1.1 History and Perspective
    • 3.1.2 Imaging Techniques
    • 3.1.3 Closed and Open Systems
    • 3.1.4 Various Designs
    • 3.15 Competing Modalities
  • 3.2 Ultrasound
    • 3.2.1 History and Perspective
    • 3.2.2 Advanced Techniques
    • 3.2.3 Competing Modalities
    • 3.2.3.2 Radiography
    • 3.3 Imaging Biomarkers
    • 3.3.1 Optimizing Drug Development
    • 3.3.2 Diagnosing Parkinson’s Disease
  • 3.4 Key Challenges and Issues
    • 3.4.1 MRI
    • 3.4.2 Ultrasound
4.0 RESEARCH EFFORTS AND TRENDS
  • 4.1 Functional MRI (fMRI) Brain Scans May Predict Behavior Better
  • 4.2 Patient, Device Selection Key to MRI Safety
  • 4.3 Molecule Analysis
  • 4.4 MRI Accuracy
  • 4.5 MRI Breast Cancer Benefits
  • 4.6 Advanced Rectal Cancer Survival
  • 4.7 Hybrid PET and MRI Imaging
  • 4.8 Combined Ultrasound and Pre-operative MRI
  • 4.9 Diffusion MRI
  • 4.10 GE-Mayo Clinic
  • 4.11 MRI Implant Safety
  • 4.12 Fusing MRI, Ultrasound
  • 4.13 Non-cardiac Ultrasound
  • 4.14 Targeted Breast Ultrasound
  • 4.15 Second Look Ultrasound
  • 4.16 Contrast Enhanced Ultrasound for Children
  • 4.17 Ultrasound Imaging with Smartphones
  • 4.18 Ultrasound Algorithm
  • 4.19 Ultrasound and CT
5.0 MARKETS
  • 5.1 Market Drivers
    • 5.1.1 MRI
    • 5.1.2 Ultrasound
  • 5.2 MRI Forecasts
    • 5.2.1 Head, Neck, Brain Scanning
    • 5.2.2 Heart-Cardio Scanning
    • 5.2.3 Breast Scans
    • 5.2.4 Geographic Analysis and Forecasts
  • 5.3 Ultrasound Forecasts
    • 5.3.1 Market Growth
    • 5.3.2 OB/Gyn
    • 5.3.3 Breast
    • 5.3.4 Traditional and Non-Traditional Markets
    • 5.3.5 Handheld Systems
    • 5.3.6 Geographic Analysis
6.0 CORPORATE PROFILES
    6.1 MRI

     

  • 6.1.1 Advanced Imaging Research Inc.
  • 6.1.2 American Magnetics Inc.
  • 6.1.3 Analogic Corp.
  • 6.1.4 B. E. Peterson Inc.
  • 6.1.6 Doty Scientific Inc.
  • 6.1.7 Esaote SpA
  • 6.1.8 Fonar Corp.
  • 6.1.9 GE Healthcare
  • 6.1.10 Hitachi Medical Systems America Inc.
  • 6.1.11 Hologic Inc.
  • 6.1.12 Imris
  • 6.1.13 InnerVision MRI Ltd.
  • 6.1.14 Invivo Corp.
  • 6.1.15 MagneVu
  • 6.1.16 Medrad Inc.
  • 6.1.17 MetPlas
  • 6.1.18 Millenium Technology Inc.
  • 6.1.19 MR Instruments Inc.
  • 6.1.20 ONI Medical Systems Inc.
  • 6.1.21 Paramed Medical Systems Inc.
  • 6.1.22 Philips Healthcare
  • 6.1.23 Resonance Research Inc.
  • 6.1.24 Siemens Healthcare
  • 6.1.25 Time Medical Systems Inc.
  • 6.1.26 Toshiba America Medical Systems

    6.2 ULTRASOUND

  • 6.2.1 Hitachi Aloka Medical Ltd.
  • 6.2.2 American Medical Design
  • 6.2.3 Analogic Corp.
  • 6.2.4 Biomedicom
  • 6.2.5 Echoson SA
  • 6.2.6 Esaote SpA
  • 6.2.7 GE Healthcare
  • 6.2.8 Hitachi Medical Systems America Inc.
  • 6.2.9 LJB Development Inc.
  • 6.2.10 Medison America Inc.
  • 6.2.11MySono.com
  • 6.2.12 Paradigm Medical Industries
  • 6.2.13 Philips Healthcare
  • 6.2.14 Shimadzu Corp.
  • 6.2.15 Siemens Healthcare
  • 6.2.16 SonoSite Inc.
  • 6.2.17 Spectromed
  • 6.2.18 Telemed
  • 6.2.19 Terason Ultrasound
  • 6.2.20 TomTec Imaging Systems GmbH
  • 6.2.21 Toshiba America Medical Systems
  • 6.2.22 Ultrasonix Medical Corp.
  • 6.2.23 Verathon Inc
  • 6.2.24 Volcano Corp.
  • 6.2.25 Zonare Medical Systems Inc.

 

LIST OF EXHIBITS

 

1.0 EXECUTIVE SUMMARY

  • Exhibit 1: World Market for Medical MRI Systems, 2010-2015
  • Exhibit 2: World Market for Medical Ultrasound Systems, 2010-2015
2.0 APPLICATIONS
  • Exhibit 3:MRI Indications
  • Exhibit 4: Head MRI Indications
  • Exhibit 5: Ultrasound Applications
5.0 MARKETS
  • Exhibit 6: Worldwide Medical MRI Installed Base
  • Exhibit 7: Worldwide Medical MRI System Prices
  • Exhibit 8: Worldwide Medical MRI System Prices
  • Exhibit 9: Key Players’ Percentage Share - Worldwide Medical MRI Equipment Market
  • Exhibit 10: Key Players’ Percentage Share - Worldwide Medical MRI Equipment Market
  • Exhibit 11: World Market for Medical MRI Systems
  • Exhibit 12: World Market for Medical MRI Systems
  • Exhibit 13: World Market for MRI Systems Used in Head, Neck and Brain Scanning
  • Exhibit 14: US Market for MRI Systems Used in Head, Neck and Brain Scanning
  • Exhibit 15: World Market for MRI Systems Used in Heart-Cardio Scanning
  • Exhibit 16: US Market for MRI Systems Used in Heart-Cardio Scanning
  • Exhibit 17: US Market for MRI Systems Used in Breast Scanning
  • Exhibit 18: North American Market for Medical MRI Systems
  • Exhibit 19: European Market for Medical MRI Systems
  • Exhibit 20: UK Market for Medical MRI Systems
  • Exhibit 21: French Market for Medical MRI Systems
  • Exhibit 22: Spanish Market for Medical MRI Systems
  • Exhibit 23: Italian Market for Medical MRI Systems
  • Exhibit 24: German Market for Medical MRI Systems
  • Exhibit 25: BRIC Market for Medical MRI Systems
  • Exhibit 26: Brazilian Market for Medical MRI Systems
  • Exhibit 27: Russian Market for Medical MRI Systems
  • Exhibit 28: Indian Market for Medical MRI Systems
  • Exhibit 29: Chinese Market for Medical MRI Systems
  • Exhibit 30: Japanese Market for Medical MRI Systems
  • Exhibit 31: Worldwide Medical Ultrasound Installed Base
  • Exhibit 32: Worldwide Medical Ultrasound Installed Base Units, 2012 (US, Europe, ROW)
  • Exhibit 33: Leading Competitors’ Market Share of the Worldwide Medical Ultrasound Market, 2012
  • Exhibit 34: World Market for Medical Ultrasound Systems 2010-2015
  • Exhibit 35: World Market for Medical Ultrasound Systems
  • Exhibit 36: World Ob/Gyn Ultrasound Systems Market
  • Exhibit 37: North American Ob/Gyn Ultrasound Systems Market
  • Exhibit 38: World Breast Ultrasound Imaging Market
  • Exhibit 39: North American Breast Ultrasound Imaging Market
  • Exhibit 40: Traditional and Non-Traditional Ultrasound System Markets
  • Exhibit 41: World and North American Handheld Medical Ultrasound Markets
  • Exhibit 42: North American Ultrasound Systems Market
  • Exhibit 43: European Ultrasound Systems Market
  • Exhibit 44: UK Market for Medical Ultrasound Systems
  • Exhibit 45: French Market for Medical Ultrasound Systems
  • Exhibit 46: Spanish Market for Medical Ultrasound Systems
  • Exhibit 47: Italian Market for Medical Ultrasound Systems
  • Exhibit 48: German Market for Medical Ultrasound Systems
  • Exhibit 49: BRIC Market for Medical Ultrasound Systems
  • Exhibit 50: Brazilian Market for Medical Ultrasound Systems
  • Exhibit 51: Russian Market for Medical Ultrasound Systems
  • Exhibit 52: Indian Market for Medical Ultrasound Systems
  • Exhibit 53: Chinese Market for Medical Ultrasound Systems
  • Exhibit 54: Japanese Market for Medical Ultrasound Systems

MEDICAL CONTRAST AGENTS

CHAPTER ONE: Executive Summary

  • Image Enhancament Overview
  • X-Ray and CT
  • Ultrasound
  • MRI
  • Radiopharmaceuticals
  • World Market Summary
  • Volume Growth
  • New Diagnostics
  • Toxicity Issues
  • Generic Competition
  • World Market Growth Analysis
  • Methodology
CHAPTER TWO: Introduction
  • Agents for the Early Detection of Disease
  • Two Functions
  • Adding Value
  • Key Clinical Markets
  • X-Ray and CT
  • Ultrasound
  • Updated Warning on Microbubbles
  • Microbubble Composition
  • Targeted and Untargeted
  • MRI
  • Novel Agents
  • Nuclear Medicine
  • Diagnosing Functionality
  • Sourcing Issues Updated
  • PET
  • New Applications
  • SPECT
  • Gamma Cameras
  • Risks
  • Ionic and Non-Ionic Contrast
  • Issues
  • Utilization Rate
  • Technical Challenges
  • Tracking Contrast Media
  • Contrast Modality Combinations
  • Emerging Applications
  • Atherosclerosis
  • Nanotechnology
CHAPTER THREE: Market Developments
  • Market Developments
  • FDA Approves Amyvid
  • Bayer HealthCare Business Integration
  • Bayer Receives Gadavist Approval
  • Agfa’s Generic Push
  • Agfa’s Generic Push
  • Improving Magnetic Resonance Visualization
  • Nanoparticle Contrast
  • Tracking Stem Cells
CHAPTER FOUR: Markets
  • Market Drivers
  • Withstanding the Recession
  • Combination Imaging and Disease Management
  • Opportunities from Increasing Specificity
  • Aging Population
  • Utilization
  • Procedures
  • Outlook for Contrast Media
  • Market Forecast
  • X-Ray and CT
  • Ultrasound
  • MRI
  • Outlook for Molecular Imaging Agents
  • Market Forecast
CHAPTER FIVE: Corporate Profiles
  • Acusphere Inc..
  • Alseres Pharmaceuticals, Inc.
  • Amag Pharmaceuticals Inc
  • Aposense Ltd
  • ART Advanced Research Technologies Inc.
  • Avid Radiopharmaceuticals Inc
  • Bayer HealthCare
  • Bracco SpA
  • Cardinal Health
  • Cell>Point
  • Covidien plc
  • Daiichi Pharmaceutucal Co. Ltd
  • Draximage
  • Endocyte Inc
  • Eusa Pharma
  • FluoroPharma Medical Inc
  • GE Healthcare
  • Guerbet Group
  • Hovione Farmaciencia SA
  • Immunomedics Inc
  • Insight Agents
  • Kereos Inc
  • King Pharmaceuticals
  • Lantheus Medical Imaging
  • Luna Nanoworks
  • Macrocyclics
  • MDS Nordion
  • Molecular Insight Pharmaceuticals, Inc
  • Nanoscan Imaginf LLC
  • Palatin Technologies Inc
  • Pharmacyclics
  • Spago Imaging AB
  • Targeson Inc
  • Taejoon Pharmaceutical Co. Ltd
  • VisEn Medical
  • Zim Laboratories India Ltd
List of Exhibits

CHAPTER ONE: Executive Summary

  • Executive SummaryExhibit 1:World Market for X-Ray Medical Contrast Media, 2011-2015
  • Exhibit 2:World Market for CT Medical Contrast Media, 2011-2015
  • Exhibit 3:World Market for Ultrasound Medical Contrast Media, 2011-2015
  • Exhibit 4:World Market for MRI Medical Contrast Media, 2011-2015
  • Exhibit 5:World Market for PET Radiopharmaceuticals, 2011-2015
  • Exhibit 6:World Market for SPECT Radiopharmaceuticals, 2011-2015
CHAPTER TWO: Introduction
  • Exhibit 7:Key Medical Contrast Agents by Type
  • Exhibit 8:Advantages of Non-Ionic Contrast Media
  • Markets Exhibit 9:Patent Status of Selected Medical Imaging Agents
CHAPTER FOUR: MARKETS
  • Exhibit 10:World Market for Medical Contrast Media and Radiopharmaceuticals, 2011-2015
  • Exhibit 11:World Market Share for Medical Contrast Media and Radiopharmaceuticals, 2011
  • Exhibit 12:World Market for Medical Contrast Media and Radiopharmaceuticals, 2015
  • Exhibit 13:Key Players’ Percentage Share – Worldwide Medical Contrast Media Market, 2012
  • Exhibit 14:World Market Geographic Segmentation for Medical X-Ray Procedures, 2012
  • Exhibit 15:World Market Geographic Segmentation for Medical X-Ray Procedures, 2012
  • Exhibit 16:Worldwide Medical MRI Procedures, 2012
  • Exhibit 17:World Market Geographic Segmentation for Medical MRI Procedures, 2012
  • Exhibit 18:Worldwide Medical CT Procedures, 2012
  • Exhibit 19:World Market Geographic Segmentation for Medical CT Procedures, 2012
  • Exhibit 20:Worldwide Medical Ultrasound Procedures, 2012
  • Exhibit 21:World Market Geographic Segmentation for Medical Ultrasound Procedures, 2012
  • Exhibit 22:Worldwide Medical PET Procedures, 2012
  • Exhibit 23:World Market Geographic Segmentation for Medical PET Procedures, 2012
  • Exhibit 24:Worldwide Medical SPECT Procedures, 2012
  • Exhibit 25:World Market Geographic Segmentation for Medical SPECT Procedures, 2012
  • Exhibit 26:Status of Selected Medical Imaging Agents
  • Exhibit 27:World Markets for X-Ray Contrast Media, 2011-2015
  • Exhibit 28:World Market for Medical X-Ray Contrast Media by Geographic Segment, 2011-2015
  • Exhibit 29:World Market for Medical X-Ray Contrast Media by Geographic Segment, 2012
  • Exhibit 30:World Market for CT Contrast Media, 2011-2015
  • Exhibit 31:World Market for Medical CT Contrast Media by Geographic Segment, 2011-2015
  • Exhibit 32:World Market for Medical CT Contrast Media by Geographic Segment, 2012
  • Exhibit 33:World Market for Ultrasound Contrast Media, 2011-2015
  • Exhibit 34:World Market for Medical Ultrasound Contrast Media by Geographic Segment, 2011-2015
  • Exhibit 35:World Market for Medical Ultrasound Contrast Media by Geographic Segment, 2012
  • Exhibit 36:World Market for MRI Contrast Media by Geographic Segment, 2011-2015
  • Exhibit 37:World Market for Medical MRI Contrast Media by Geographic Segment, 2011-2015
  • Exhibit 38:World Market for Medical MRI Contrast Media by Geographic Segment, 2012
  • Exhibit 39:Selected Molecular Imaging Products
  • Exhibit 40:World Market for Medical PET Radiopharmaceuticals, 2011-2015
  • Exhibit 41:World Market for Medical PET Radiopharmaceuticals by Geographic Segment, 2011-2015
  • Exhibit 42 :World Market for Medical PET Radiopharmaceuticals by Geographic Segment, 2012
  • Exhibit 43:World Market for Medical SPECT Radiopharmaceuticals, 2011-2015
  • Exhibit 44:World Market for Medical SPECT Radiopharmaceuticals by Geographic Segment, 2011-2015

  • MEDICAL IMAGING MARKETS:  MOLECULAR IMAGING


    1.0 EXECUTIVE SUMMARY
    1.1 Molecular Basis of Cell Function
    1.1.1 Personalized Medicine
    1.2 Driving Health Care
    1.3 Multicapabilities
    1.4 The Power of Imaging
    1.4.1 Key Modalities
    1.5 World Market Summary
    1.5.1 Market Drivers and Challenges
    1.5.2 Growth Analysis
    1.6 Methodology
    2.0 INTRODUCTION
    2.1 Definition
    2.1.1 Visualizing Biological Events
    2.1.2 For Diagnosis and More
    2.1.3 Molecular Agents
    2.2 New Direction for Medicine
    2.3 Modalities and Applications
    2.3.1 Nuclear Medicine
    2.3.1.1 PET
    2.3.1.1.1 Understanding Disease Mechanisms
    2.3.1.2 SPECT and Gamma Cameras
    2.3.3 MRI
    2.3.4 Ultrasound
    2.3.5 Fusion Imaging
    2.3.5.1 Dual-Modality Advantages
    2.3.5.2 PET/CT
    2.3.5.3 SPECT/CT
    2.3.5.4 PET/MRI
    2.3.5.4.1 Therapeutic Successes
    2.3.6 Optical Imaging
    2.4 Drivers
    2.4.1 Complementary Opportunities
    2.4.2 Preventive Medicine
    2.5 Issues and Challenges
    2.5.1 Dual modality Issues
    2.5.2 Standardization Needed
    2.5.3 Addressing Radiopharmaceutical Shortages
    2.5.4 Signaling Improvements, Equipment Configurations Needed
    2.5.5 Advances in Devices and Software
    2.6 Health Care Reform
    2.6.1 Utilization Rate
    2.6.2 Tax Concerns
    3.0 RESEARCH IMPACTING THE MARKET
    3.1 Diagnosing Fever of Unknown Origin
    3.2 Determine Malignancy in Potential Ovarian Cancer
    3.3 PET/CT Impacts Brain Tumor Management
    3.4 Improving Care for Neuroendocrine Cancer
    3.5 PET Optimizes Virtual Colonoscopy
    3.6 Staging Prostate Cancer
    3.7 Cyclotron Expansion
    3.8 Breast Cancer Screening
    3.9 PET Indicates Therapy Effectiveness
    3.10 Lower Dosage in Hybrid Imaging
    3.11 Analyze Differences in Biochemical Status of Tissues
    3.12 Myocardial Flow Reserve Analysis
    4.0 MARKETS
    4.1 Overview
    4.1.1 Growth In Cardiology
    4.1.2 Merging Diagnosis and Treatment
    4.2 Procedures
    4.3 Forecasts
    4.3.1 PET
    4.3.1.1 PET/CT
    4.3.1.1.1 Time of Flight Impact
    4.3.2 SPECT-Gamma Camera Systems
    4.3.2.1 SPECT/CT
    4.3.2.1.1 Driven by Cardiology
    4.3.3 MRI
    4.3.4 CT
    4.3.5 Ultrasound
    5.0 CORPORATE PROFILES
    5.1 ABT Molecular Imaging Inc.
    5.2 Advanced Cyclotron Systems Inc.
    5.3 Aspect Imaging
    5.4 Avid Radiopharmaceuticals Inc.
    5.5 Bioscan
    5.6 Cardinal Health
    5.7 Digirad Corp.
    5.8 Dilon Diagnostics
    5.9 Gamma Medica Inc.
    5.10 GE Healthcare
    5.11 Imaging Diagnostic Systems Inc.
    5.12 MIR Preclinical Services
    5.13 OptoSonics Inc.
    5.14 Philips Healthcare
    5.15 Photo Diagnostic Systems
    5.16 Positron Corp.
    5.17 Shimadzu Corp.
    5.18 Siemens Healthcare
    5.19 Spectrum Dynamics Ltd.
    5.20 Toshiba America Medical Systems
    5.21 UltraSPECT Ltd.
    5.22 VisEn Medical
    5.23 Zecotek Photonics Inc. Unit 1120
    LIST OF EXHIBITS
    1.0 EXECUTIVE SUMMARY
    Exhibit 1: World Market for PET, 2011-2015
    Exhibit 2: World Market for SPECT, 2011-2015
    Exhibit 3: World Market for Molecular CT, 2011-2015
    Exhibit 4: World Market for Molecular MRI, 2011-2015
    Exhibit 5: World Market for Molecular Ultrasound, 2011-2015
    Exhibit 6: World Market for PET/CT, 2011-2015
    Exhibit 7: World Market for SPECT/CT, 2011-2015
    2.0 INTRODUCTION
    Exhibit 8: Key Radionuclides
    4.0 MARKETS
    Exhibit 9: Worldwide SPECT Procedures, 2012 (Cardio., Cancer, Neuro.)
    Exhibit 10: US SPECT Procedures, 2012 (Cardio., Cancer, Neuro.)
    Exhibit 11: Worldwide PET Procedures, 2012 (Cardio., Cancer, Neuro.)
    Exhibit 12: US PET Procedures, 2012 (Cardio., Cancer, Neuro.)
    Exhibit 13: Worldwide Molecular CT Procedures, 2012 (US, EU, ROW)
    Exhibit 14: Worldwide Molecular MRI Procedures, 2012 (US, EU, ROW)
    Exhibit 15: World Medical Market for PET Systems, 2011-2015
    Exhibit 16: World Medical Market for PET Systems by Geographic Segment, 2011-2015 (U.S., Europe, BRIC, Japan, ROW)
    Exhibit 17: World Medical Market for PET/CT Systems, 2011-2015
    Exhibit 18: World Medical Market for PET/CT Systems by Geographic Segment, 2011-2015 (U.S., Europe, BRIC, Japan, ROW)
    Exhibit 19: World Medical Market for PET Systems by Geographic Segment, 2012
    Exhibit 20: Worldwide Medical PET Installed Base, 2012 (U.S., World)
    Exhibit 21: World Medical Market for SPECT Systems, 2011-2015
    Exhibit 22: World Medical Market for SPECT Systems by Geographic Segment, 2011-2015 (U.S., Europe, BRIC, Japan, ROW)
    Exhibit 23: World Medical Market for SPECT/CT Systems, 2011-2015
    Exhibit 24: World Medical Market for SPECT/CT Systems by Geographic Segment, 2011-2015 (U.S., Europe, BRIC, Japan, ROW)
    Exhibit 25: World Medical Market for SPECT Systems by Geographic Segment, 2012
    Exhibit 26: Worldwide Medical SPECT Installed Base, 2012
    Exhibit 27: World Medical Market for MRI Molecular Imaging Systems, 2011-2015
    Exhibit 28: World Medical Market for MRI Molecular Imaging Systems by Geographic Segment, 2011-2015 (U.S., Europe, BRIC, Japan, ROW)
    Exhibit 29: World Medical Market for MRI Molecular Imaging Systems by Geographic Segment 2012
    Exhibit 30: World Medical Market for CT Molecular Imaging Systems 2011-2015
    Exhibit 31: World Medical Market for CT Molecular Imaging Systems by Geographic Segment, 2011-2015 (U.S., Europe, BRIC, Japan, ROW)
    Exhibit 32: World Medical Market for CT Molecular Imaging Systems by Geographic Segment, 2012
    Exhibit 33: World Medical Market for Ultrasound Molecular Imaging Systems, 2011-2015
    Exhibit 34: World Medical Market for Ultrasound Molecular Imaging Systems by Geographic Segment, 2011-2015
    Exhibit 35: World Medical Market for Ultrasound Molecular Imaging Systems by Geographic Segment, 2012
    Exhibit 45:World Market for Medical SPECT Radiopharmaceuticals by Geographic Segment, 2012

In this report, {{keyword[keywordTextProperty]}} appears {{keyword[keywordCountProperty]}} times. {{searchResults.STATRESULT.SUMMARY.KW[keywordTextProperty]}} appears {{searchResults.STATRESULT.SUMMARY.KW[keywordCountProperty]}} times.

We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.